AKERO THERAPEUTICS INC's ticker is and the CUSIP is 00973Y908. A total of 2 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,623 | +461.6% | 32,100 | +417.7% | 0.00% | – |
| Q2 2023 | $289 | -64.0% | 6,200 | -70.5% | 0.00% | -100.0% |
| Q1 2023 | $803 | -38.7% | 21,000 | -12.1% | 0.00% | 0.0% |
| Q4 2022 | $1,309 | -99.9% | 23,900 | -19.0% | 0.00% | 0.0% |
| Q3 2022 | $1,004,000 | +25000.0% | 29,500 | +5800.0% | 0.00% | – |
| Q2 2022 | $4,000 | +300.0% | 500 | +400.0% | 0.00% | – |
| Q1 2022 | $1,000 | -91.7% | 100 | -83.3% | 0.00% | – |
| Q4 2021 | $12,000 | -70.0% | 600 | -62.5% | 0.00% | – |
| Q3 2021 | $40,000 | +2.6% | 1,600 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | -53.6% | 1,600 | +5417.2% | 0.00% | – |
| Q1 2021 | $84,000 | -68.1% | 29 | -71.6% | 0.00% | – |
| Q4 2020 | $263,000 | +13050.0% | 102 | +10100.0% | 0.00% | – |
| Q2 2020 | $2,000 | -92.6% | 1 | -92.3% | 0.00% | – |
| Q1 2020 | $27,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 3,600 | $104,000 | 0.00% |
| SIMPLEX TRADING, LLC | 29 | $84,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |